| Website | orayainc.com |
| Category | BioTech |
| Phone | 510-456-3700 |
| Employees | |
| Description | Robitic treatments for Eye Inflammations |
| Total | $64M |
| Series A, 6/07 Essex Woodlands Health Ventures | $4M |
| Series B, 1/08 Synergy Life Sciences Partner Essex Woodlands Health Ventures | $18M |
| Series C, 7/09 Domain Associates Scale Venture Partners Synergy Life Sciences Partner Essex Woodlands Health Ventures | $42M |
Oraya Therapeutics is currently testing its first application of the IRay system. Oraya Therapeutics develops noninvasive robotically controlled treatments for inflammatory and neovascular diseases of the eye.
